{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:41:01Z","timestamp":1793724061194,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["SGG20220606142 207017"],"award-info":[{"award-number":["SGG20220606142 207017"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ymthe.2025.02.037","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T02:50:17Z","timestamp":1740711017000},"page":"1720-1734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A universal viral capsid protein based one step RNA synthesis and packaging system for rapid and efficient mRNA vaccine development"],"prefix":"10.1016","volume":"33","author":[{"given":"Jiayue","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4765-184X","authenticated-orcid":false,"given":"Zeliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.02.037_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114000","article-title":"Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic","volume":"179","author":"Jain","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2025.02.037_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.747032","article-title":"Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief","volume":"12","author":"Andersen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.02.037_bib3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1021\/acs.nanolett.9b03483","article-title":"Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination","volume":"20","author":"Son","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2025.02.037_bib4","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T\u00a0cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.02.037_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041223","article-title":"Establishment of an Antiplasmodial Vaccine Based on PfRH5-Encoding RNA Replicons Stabilized by Cationic Liposomes","volume":"15","author":"Fotoran","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2025.02.037_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0603","article-title":"Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination","volume":"15","author":"Suberi","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.02.037_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T\u00a0cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.ymthe.2025.02.037_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.02.037_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1039\/D2BM01581A","article-title":"Lipid nanoparticle-based mRNA candidates elicit potent T\u00a0cell responses","volume":"11","author":"Zeng","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ymthe.2025.02.037_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of Lipid Nanoparticles for RNA Delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ymthe.2025.02.037_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/biot.201500147","article-title":"Alphavirus capsid proteins self-assemble into core-like particles in insect cells: A promising platform for nanoparticle vaccine development","volume":"11","author":"Hikke","year":"2016","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ymthe.2025.02.037_bib12","article-title":"N-terminal VP1 Truncations Favor T\u00a0= 1 Norovirus-Like Particles","volume":"9","author":"Pogan","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2025.02.037_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/nnm-2023-0362","article-title":"Virus-like particles derived from bacteriophage MS2 as antigen scaffolds and RNA protective shells","volume":"19","author":"Naskalska","year":"2024","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ymthe.2025.02.037_bib14","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1021\/acsbiomaterials.4c00770","article-title":"Deciphering the Thermal Stability of Bacteriophage MS2-Derived Virus-like Particle and Its Engineered Variant","volume":"10","author":"Vishwakarma","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ymthe.2025.02.037_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/nat.2016.0660","article-title":"Virus-Like Particles of mRNA with Artificial Minimal Coat Proteins: Particle Formation, Stability, and Transfection Efficiency","volume":"27","author":"Jekhmane","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.ymthe.2025.02.037_bib16","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1093\/nar\/21.19.4621","article-title":"Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein","volume":"21","author":"Pickett","year":"1993","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.02.037_bib17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jmb.2010.05.037","article-title":"The impact of viral RNA on the association rates of capsid protein assembly: bacteriophage MS2 as a case study","volume":"400","author":"Elsawy","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.02.037_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000067930","article-title":"RNA bacteriophage capsid-mediated drug delivery and epitope presentation","volume":"45","author":"Brown","year":"2002","journal-title":"Intervirology"},{"key":"10.1016\/j.ymthe.2025.02.037_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/260500a0","article-title":"Complete nucleotide sequence of bacteriophage MS2 RNA: primary and secondary structure of the replicase gene","volume":"260","author":"Fiers","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.02.037_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s43246-022-00229-3","article-title":"Programmable polymorphism of a virus-like particle","volume":"3","author":"Biela","year":"2022","journal-title":"Commun. Mater."},{"key":"10.1016\/j.ymthe.2025.02.037_bib21","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ja031790q","article-title":"Interior surface modification of bacteriophage MS2","volume":"126","author":"Hooker","year":"2004","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2025.02.037_bib22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jmcb\/mjz091","article-title":"IRES-mediated cap-independent translation, a path leading to hidden proteome","volume":"11","author":"Yang","year":"2019","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.02.037_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.01.005","article-title":"Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease","volume":"117","author":"Dong","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ymthe.2025.02.037_bib24","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.2147\/IJN.S37990","article-title":"MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice","volume":"7","author":"Pan","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ymthe.2025.02.037_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081865","article-title":"Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy Development","volume":"10","author":"Marques","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2025.02.037_bib26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.02.037_bib27","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials on mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2025.02.037_bib28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","article-title":"A Thermostable mRNA Vaccine against COVID-19","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.02.037_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.02.037_bib30","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/s41467-023-38751-8","article-title":"An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants","volume":"14","author":"Tai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.02.037_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: The COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2025.02.037_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biopha.2008.07.086","article-title":"Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide","volume":"63","author":"Wei","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2025.02.037_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.02.037_bib34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mt.2012.250","article-title":"Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy","volume":"21","author":"Wang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.02.037_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/hum.2018.145","article-title":"Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response","volume":"30","author":"Foster","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.02.037_bib36","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/acs.molpharmaceut.4c00826","article-title":"Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects","volume":"21","author":"Kafle","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2025.02.037_bib37","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.7150\/thno.82873","article-title":"Improved extracellular vesicle-based mRNA delivery for familial hypercholesterolemia treatment","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.02.037_bib38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fimmu.2019.00172","article-title":"MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.02.037_bib39","article-title":"Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment","volume":"11","author":"Gao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.02.037_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98706-1","article-title":"Optimizing the synthesis and purification of MS2 virus like particles","volume":"11","author":"Hashemi","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:07:44Z","timestamp":1775102864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1525001625001273"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.037","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A universal viral capsid protein based one step RNA synthesis and packaging system for rapid and efficient mRNA vaccine development","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}